Free Trial
NASDAQ:BNKK

Bonk Q3 2025 Earnings Results & Report

Bonk logo
$1.24 -0.05 (-3.88%)
As of 09:56 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Bonk reported Q3 2025 earnings on November 19, 2025. The company reported EPS of -$3.85, while revenue was $1.51 million.

Earnings Announcement Details

Quarter
Q3 2025
Time
After Market Closes

Bonk EPS Results

Actual EPS
-$3.85
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bonk Revenue Results

Actual Revenue
$1.51 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Bonk Q3 2025 Earnings FAQ

Bonk (NASDAQ:BNKK) reported earnings of -$3.85 per share for Q3 2025. The report was announced on Wednesday, November 19, 2025.

Bonk reported revenue of $1.51 million for Q3 2025.

Bonk Earnings Headlines

Flyers Make More Roster Moves in Latest Attempt to Course-Correct
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday. That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves. Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts.tc pixel
Contrasting Remitly Global (NASDAQ:RELY) & Bonk (NASDAQ:BNKK)
Bonk (BONK) Price Prediction: 2025, 2026, 2030
See More Bonk Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bonk? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bonk and other key companies, straight to your email.

About Bonk

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.

View Bonk Profile